We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BMS, Watson Named in Pravachol Patent Infringement Complaint
BMS, Watson Named in Pravachol Patent Infringement Complaint
January 9, 2007
The production, sale and distribution of Pravachol and generic pravastatin sodium by Bristol-Myers Squibb (BMS) and Watson
Pharmaceuticals are being challenged in federal court.